| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |